knowledge -WSS

knowledge

author：comprehensive 2025-10-02 20:49:50 - browse：2194

Portrait of Suhas Gondi. -- health coverage from STAT — Suhas Gondi of Brigham and Women's Hospital has researched and written about hospital boards increasingly being made up of private equity executives and others from outside medicine. Jonathan Wiggs/Globe Staff

Discontent among Mass General Brigham doctors had been at a slow burn for years. But when an unexpected announcement from the chief executive titled “A message about our future” popped into inboxes one morning last month, that frustration seemed to fully ignite.

Mass General Brigham, a dominant force in Boston medicine, was launching the latest and perhaps most contentious step in its ongoing effort to merge its two flagship Harvard-affiliated medical centers: combine all departments and divisions at both hospitals in a move that executives argued would improve patient care and access.

But after years of feeling shut out of decisions amid grinding work schedules, many doctors worried the changes would lead to layoffs, demotions, and an even greater loss of autonomy. During an online ‘‘town hall’’ on April 4, they inundated leaders with skeptical questions. One physician asked how executives planned to build trust with faculty when so many felt “unheard, devalued, disempowered, and unseen.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Bird flu surveillance in wastewater gets boost from consortium

WSS

In science, is the line between industry and academia shifting?

FDA panel gives mixed vote on blood pressure devices

Study finds gene variants tied to breast cancer risk in Black women

Cue Health, Covid

UnitedHealth argues against case alleging wrongful AI care denials

Apellis safety probe of eye disease drug centers on injection needle

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Peter Hotez and the public health issue of online harassment

FDA panel gives mixed vote on blood pressure devices

United colonoscopy coverage change 'may cost lives,' doctors say

As a primary care physician, here's how I hope to partner with AI

Dobbs anniversary: the lost opportunity of abortion as health care

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

New air purifier tech could be key to improving indoor air quality

CDC advisory panel says seniors 'may' get RSV vaccine

As demand for Covid shots wanes, Moderna seeks its next success

In science, is the line between industry and academia shifting?

focus

Neuroscience startup Neumora files for IPO

What AAP's gender

Neuroscience startup Neumora files for IPO

How a symptom of dementia informs our understanding of creativity

For longer

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

explore

leisure time

explore

entertainment